This contract expires in 167 days (Apr 10, 2027).
RIZLAB HEALTH INC - RESEARCH AND DEVELOPMENT- AOI #16+ SEEKING TO MANUFACTURE AND OBTAIN REGULATORY APPROVAL FOR THE CYTOTRACKER BV, A POINT-OF-CARE INSTANT WHITE BLOOD CELL ANALYSIS PLATFORM FOR DISCRIMINATING BETWEEN ACUTE VIRAL AND BACTERIAL INFECTIONS.
Key Details
Description
RESEARCH AND DEVELOPMENT- AOI #16+ SEEKING TO MANUFACTURE AND OBTAIN REGULATORY APPROVAL FOR THE CYTOTRACKER BV, A POINT-OF-CARE INSTANT WHITE BLOOD CELL ANALYSIS PLATFORM FOR DISCRIMINATING BETWEEN ACUTE VIRAL AND BACTERIAL INFECTIONS.
Context & Analysis
On Feb 9, 2026, Department of Health and Human Services obligated $2,483,472 to RIZLAB HEALTH INC for research and development- aoi #16+ seeking to manufacture and obtain regulatory approval for the cytotracker bv, a point-of-care instant white blood cell analysis platform for discriminating between a…. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PRINCETON, NJ. The contract is scheduled through Apr 10, 2027 — approximately 6 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Related Opportunities
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE.BARDA - ASPR / DAAPPO / BARDA DCMA
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE.BARDA - ASPR / DAAPPO / BARDA DCMA
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.